No abstract available
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics*
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Aryl Hydrocarbon Hydroxylases / genetics
-
Biomarkers, Pharmacological*
-
Cardiovascular Abnormalities / chemically induced
-
Celecoxib
-
Cyclooxygenase 1 / genetics
-
Cyclooxygenase 1 / metabolism
-
Cyclooxygenase 2 / genetics
-
Cyclooxygenase 2 / metabolism
-
Cyclooxygenase 2 Inhibitors / adverse effects
-
Cyclooxygenase 2 Inhibitors / pharmacokinetics*
-
Cyclooxygenase 2 Inhibitors / therapeutic use
-
Cytochrome P-450 CYP2C9
-
Genetic Association Studies
-
Humans
-
Inflammation / drug therapy*
-
Metabolic Networks and Pathways / genetics
-
Pyrazoles / adverse effects
-
Pyrazoles / pharmacokinetics*
-
Pyrazoles / therapeutic use
-
Sulfonamides / adverse effects
-
Sulfonamides / pharmacokinetics*
-
Sulfonamides / therapeutic use
-
Treatment Outcome
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Biomarkers, Pharmacological
-
Cyclooxygenase 2 Inhibitors
-
Pyrazoles
-
Sulfonamides
-
CYP2C9 protein, human
-
Cytochrome P-450 CYP2C9
-
Aryl Hydrocarbon Hydroxylases
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
PTGS1 protein, human
-
PTGS2 protein, human
-
Celecoxib